Home News Company in the news

BioNTech to open regional HQ and vaccine manufacturing facility in Singapore

Atiqah Mokhtar
Atiqah Mokhtar5/10/2021 03:02 PM GMT+08  • 2 min read
BioNTech to open regional HQ and vaccine manufacturing facility in Singapore
The German biotech company plans to make Singapore its regional hub for Southeast Asia.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

German biotech company BioNTech plans to establish regional headquarters for Southeast Asia in Singapore. It also plans to open its first production facility in Singapore to manufacture mRNA-based vaccines with support from the Singapore Economic Development Board (EDB).

According to a press release dated May 10, the new facility will produce a range of mrNA vaccines and therapeutics for infections diseases and cancer, with an estimated annual capacity of several hundred of million doses of mRNA-based vaccines depending on the specific vaccine.

BioNTech plans to open its Singapore office and initiate construction of the manufacturing facility in 2021, subject to planning approval. The company anticipates that the site could be operational as early as 2023 and will create up to 80 jobs in Singapore.

SEE:Pfizer to deliver US vaccine doses by end May

Ugur Sahin, CEO and co-founder of BioNTech, says that the production facility in Singapore will increase the company’s overall capacity and network. “Singapore provides an excellent business climate, growing biotechnology industry and rich talent base,” he says.

“We strongly welcome BioNTech’s plan to establish its mRNA manufacturing facility and regional headquarters in Singapore. The investment will enable Singapore to develop capabilities in an important new therapeutic modality as part of the strategy to grow our biopharmaceutical industry,” said Beh Swan Gin, EDB chairman.

“In particular, BioNTech’s mRNA manufacturing facility will contribute significantly to the region’s ability to address future pandemic threats,” he adds.

BioNTech's move to expand to Southeast Asia follows the opening of its US headquarters in Cambridge, Massachusetts in 2020.

Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.